RESVINET
  • Home
  • About RSV
    • professionals
    • Publications
  • about us
    • The foundation
    • ReSViNET Team
    • contact us >
      • Support us >
        • Webshop
        • Donate
  • Conference
    • RSVVW'23 >
      • RSVVW'23 Home
      • Registration Fees
      • Visa
      • Accommodation
      • Abstract Submission
      • Young Researchers' Tournament
      • Poster Presentation
      • Accreditation
      • Speakers' Information
    • Previous conferences >
      • RSVVW'21
      • RSVVW'19
      • 4th Meeting 2017
      • 3rd Meeting 2017
      • 2nd Expert Meeting
      • 1st Expert Meeting
  • Webinar Series
  • patient network
    • Activities >
      • Webinars
    • RSV Awareness Week
    • Patient Advisory Board
    • Promise
    • RSV reading material
    • contact patient network
  • Home
  • About RSV
    • professionals
    • Publications
  • about us
    • The foundation
    • ReSViNET Team
    • contact us >
      • Support us >
        • Webshop
        • Donate
  • Conference
    • RSVVW'23 >
      • RSVVW'23 Home
      • Registration Fees
      • Visa
      • Accommodation
      • Abstract Submission
      • Young Researchers' Tournament
      • Poster Presentation
      • Accreditation
      • Speakers' Information
    • Previous conferences >
      • RSVVW'21
      • RSVVW'19
      • 4th Meeting 2017
      • 3rd Meeting 2017
      • 2nd Expert Meeting
      • 1st Expert Meeting
  • Webinar Series
  • patient network
    • Activities >
      • Webinars
    • RSV Awareness Week
    • Patient Advisory Board
    • Promise
    • RSV reading material
    • contact patient network

PETER RICHMOND

Chairman of the board
  • Current Position(s): Associate Professor and Head of Division of Paediatrics, The University of Western Australia, Faculty of Health and Medical Sciences; School of Medicine, (M561), Director, Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases, Head, Department Child Health Research, Perth Children’s Hospital, Director, Child Health Research Network, Children and Adolescent Health Service
  • Workplace: The University of Western Australia and Perth Children’s Hospital 
  • Title: MBBS, MRCP(UK), FRACP
  • Education: MB BS, University of Western Australia, MRCP (Member of the Royal College of Physicians), London, FRACP (Fellow of Royal Australasian College of Physicians) Australia, Education Commission for Foreign Medical Graduates Certificate USA, Griffiths Developmental Assessment Diploma, State Child Development Centre Perth
  • Specific expertise for ReSViNET foundation
    Peter Richmond  leads the Vaccine
    Trials and Ear Health Groups in the Wesfarmers Centre of Vaccines and Infectious Diseases (WCVID)
    based at the Telethon Kids Institute. He has led a vaccine research group in Perth attracting over $25
    million in government, competitive, and industry funding with continuous NHMRC funding since
    2003 that supports 20 FTE in research staff and postgraduate students conducting high quality
    epidemiological, clinical, immunological and microbiological research in children and adults with
    strong community support. His laboratory for assessment of humoral and cell mediated immune
    responses to vaccines and bacterial pathogens is recognized internationally.
    He has specific experience in large scale  ARLI/pneumonia aetiology clinical and data-linkage studies, RSV vaccine and monoclonal antibody clinical trials in infants, children and pregnant mothers and viral vaccine efficacy studies in children and adults. He has undertaken clinical trials in Australia and Papua New Guinea. He is also an Investigator at the Linear Phase I trial facility in Perth.
Picture
Note: All information on ReSViNET is for educational purposes only. For specific medical advice, diagnoses, and treatment, consult your doctor.

© 2021 ReSViNET Foundation. All rights reserved.
About us
Disclosure
Contact